Company signals · MedTech
Stryker
2 signals in the current window, with MitchelLake's leadership read on each.
Market context: The wider read — a Talent Market Index of 98.6 (Neutral), down 1.4 month-on-month — shows Asia signal flow rising (+2.4pts).
Stryker: 2 signals in the last 90 days — above the MedTech median of 1 across 18 tracked companies; 0.2% of MitchelLake's Asia signal flow; 2 tracked across 12 days.
Signals at Stryker
Product Launch
OceaniaStryker launched TPX HD, a new small bone power tool for orthopaedic surgery supporting complex procedures including total joint revisions, minimally invasive surgery, and oral maxillofacial operations
Leadership read: Product momentum tends to widen medtech product and commercial leadership bench strength.
curated · 2026-06-03 · context →
Geographic Expansion
AsiaStryker has established APAC operations with dedicated VP and General Manager role, indicating significant regional investment in medical technologies
Leadership read: Market entry of this kind typically deepens demand for medtech leadership bench strength in the region over the following 12–18 months.
curated · 2026-05-22 · context →
MitchelLake in this thematic
More signals across MedTech
Geographic Expansion · Asia
HistoSonics →HistoSonics received regulatory approval from Taiwan's FDA for its Edison Histotripsy System, marking a significant step in expansion into Asia
Partnership · Asia
ZEISS Medical Technology →ZEISS Medical Technology signed a strategic agreement with Aier Eye Hospital Group for purchase and installation of 25 ZEISS VISUMAX 800 femtosecond lasers across multiple locations
Geographic Expansion · Oceania
Dedalus →Dedalus is expanding its diagnostic imaging portfolio into Australia and has appointed a senior business lead to drive the initiative
Product Launch · EMEA
Abbott →Abbott launched CE-marked dual glucose-ketone Libre Duo sensors in Europe through expanded partnership with MiniMed, representing first-of-its-kind dual-analyte diabetes technology
Partnership · EMEA
Cepheid →Cepheid launched landmark 30-month study with the Fleming Initiative at London NHS Trusts to evaluate rapid CPE screening for drug-resistant infections
Ma Activity · EMEA
Medtronic →Medtronic completed its acquisition of Scientia Vascular, integrating neurovascular access and therapeutic portfolios.
Intelligence powered by Autonodal ↗